The NRAS mutation is found in several cancers such as melanoma (13 ~ 25%), colorectal cancer (1 ~ 6%), lung cancer (1%), thyroid cancer (7%) and hepatocellular carcinoma (10%). It is known that the response to colorectal cancer drug such as Erbitux and Cetuximab decreased and the prognosis of the patient with metastatic colorectal cancer is poor if the patient has NRAS mutation.
PNAClamp™ Mutation Detection Kit NRAS
For detection of NRAS mutations in tissue biopsies
Cat. No. PNAC-1101
Other products
CannaSEX PCR
Kit for the determination of the sexual dimorphism of Cannabis...
Reverse Transcription Kit – RP1300
It is a kit for synthesizing high quality first strand...
PathoSEEK® Fungi and mite detection assays
PathoSEEK® screening tests for early plant health are used to...
nUVaClean UV pipette carousel – P5590
MTC's ProPette nUVaClean™ is the first and only pipette holder...